High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay.

Abstract

Atherosclerosis leads to cardiovascular disease (CVD). It is still unclear whether cholesterol-HDL (cHDL) concentration plays a causal role in atherosclerosis development. However, an important factor in early stages of atheroma plaque formation is cholesterol efflux capacity to HDL (the ability of HDL particles to accept cholesterol from macrophages) in order to avoid foam cell formation. This is a key step in avoiding the accumulation of cholesterol in the endothelium and a part of reverse cholesterol transport (RCT) to eliminate cholesterol through the liver. Cholesterol efflux capacity to serum or plasma in macrophage cell models is a promising tool that can be used as biomarker for atherosclerosis. Traditionally, [3H]-cholesterol has been used in cholesterol efflux assays. In this study, we aim to develop a safer and faster strategy using fluorescent labelled-cholesterol (NBD-cholesterol) in a cellular assay to trace the cholesterol uptake and efflux process in THP-1-derived macrophages. Finally, we optimize and standardize the NBD-cholesterol efflux method and develop a high-throughput analysis using 96-well plates.

• Authors: Roque Pastor-Ibáñez, Mireia Arnedo, Olivia Tort
• Journal: Journal of visualized experiments : JoVE (J Vis Exp) Issue 143 (01 07 2019) ISSN: 1940-087X [Electronic] United States
• PMID: 30663699 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Video-Audio Media)

Chemical References

• Cholesterol
• 4-Chloro-7-nitrobenzofurazan

Topics

• 4-Chloro-7-nitrobenzofurazan (metabolism)
• Animals
• Biological Assay (methods)
• Biological Transport
• Cholesterol (blood, chemistry, metabolism)
• HIV Infections (blood)
• Humans
• Staining and Labeling
• THP-1 Cells